Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Xolair Prefilled Syringe, Xolair
Synonyms :
omalizumab
Class :
Anti-asthmatic, monoclonal antibody
Brand Name :
Xolair Prefilled Syringe, Xolair
Synonyms :
omalizumab
Class :
Anti-asthmatic, monoclonal antibody
Dosage Forms & StrengthsÂ
InjectionÂ
Single-dose prefilled syringeÂ
75mg/0.5mlÂ
150mg/mlÂ
Reconstitution of lyophilized powderÂ
150mg/vialÂ
125mg/ml Â
150 - 375
mg
Subcutaneous (SC)
every 2-4 weeks
150 - 375
mg
Subcutaneous (SC)
every 2-4 weeks
Dosage Forms & StrengthsÂ
InjectionÂ
Single-dose prefilled syringeÂ
75mg/0.5mlÂ
150mg/mlÂ
Reconstitution of lyophilized powderÂ
150mg/vialÂ
125mg/ml Â
<6 years: Safety and efficacy not established
6 to <12 years: 75-375mg subcutaneous every 2-4 weeks
≥12 years: 150-375mg subcutaneous every 2-4 weeks
<12 years: Safety and efficacy not established
≥12 years: 150-300mg subcutaneous every four weeks
may increase the toxic effects of each other
it may decrease the therapeutic effect of Fc Receptor-Binding Agents
Frequency defined:Â Â
>10%Â
Reaction at the site of injectionÂ
HeadacheÂ
1-10%Â
Nasal polypsÂ
Upper abdominal painÂ
DizzinessÂ
HeadacheÂ
ArthralgiaÂ
Injection site reactionÂ
Chronic urticariaÂ
NauseaÂ
SinusitisÂ
NasopharyngitisÂ
Upper respiratory tract infectionÂ
Pain Â
DizzinessÂ
EaracheÂ
DermatitisÂ
FractureÂ
ArthralgiaÂ
Leg painÂ
FatigueÂ
PruritisÂ
Arm painÂ
Pregnancy consideration: AÂ
Lactation: Excretion of the drug in breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: OmalizumabÂ
Pronounced: [ OH-ma-LIZ-oo-mab]Â
Why do we use Omalizumab?Â
It is used to treat and reduce allergic reactions in the body like chronic hives, nasal polyps, and asthmaÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
